BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced that it has garnered the "Cancer Immunology Solution of the Year" award in the fourth annual ...

Study finds 11% of U.S. adults used dietary supplements for immune support pre-pandemic, emphasizing the importance of ...

The study of the relationship between the immune system and various microbiomes is a rapidly evolving field that offers significant insights into the ...

Vitamin A offers many health benefits, from skin health to immune support. Learn more about benefits and possible risks of ...

A new study reveals that individuals with allergic rhinitis and asthma have distinct nasal fungal profiles, hinting at ...

Dr. Carlos Correa discusses the impact of evergreening strategies on access to generic and biosimilar medicines globally.

The FDA has approved Bavarian Nordic’s Vimkunya, the first virus-like particle (VLP) chikungunya vaccine for patients over 12 years of age. According to the company, approval was based on strong ...

PORTLAND, OR, UNITED STATES, February 7, 2025 /EINPresswire / -- The global ulcerative colitis (UC) market is ex ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger ...